论文部分内容阅读
Ｗａｒｎｅｒ Ｌａｍｂｅｒｔ公司的子公司Ａｇｏｕｒｏｎ已开始对其抗病毒药ＡＧ70 88进行治疗感冒的Ⅱ期临床试验。这项在美国进行的大规模试验将在 90 0名初现感冒症状 36小时内的患者身上进行。该公司称 ,这是考查此产品对自然感冒患者治疗的首次试验 (先前的Ⅱ期临床试验
Agouron, a unit of Warner Lambert Inc., has started a Phase II clinical trial of its antiviral AG70 88 for the treatment of colds. The large-scale trial in the United States will be conducted on 90 0 patients within 36 hours of presenting with cold symptoms. The company said it was the first trial to examine the treatment of patients with natural cold for this product (previous Phase II clinical trial